by Grow Up Conference | Jun 17, 2024 | Cannabis News Wire, Media Partners
As Florida governor Ron DeSantis campaigns against a ballot initiative for cannabis legalization, he has paradoxically vetoed a bill aimed at banning the sale of intoxicating hemp-derived cannabinoids in the state. This decision comes in the wake of reports that Governor DeSantis intended to block the hemp prohibition bill, hoping the hemp industry would financially support his campaign against the cannabis measure that voters will decide on in November.
Although DeSantis did not explicitly reference the cannabis legalization measure in his veto letter, he noted that while the goals of SB 1698 are admirable, the measure would impose significant regulatory burdens on small entities and likely fail to achieve its objectives. He expressed concern that the bill would cause substantial harm and disruption to many manufacturing and small retail businesses in the state, which have thrived due to new laws legalizing the use of hemp for commercial purposes.
Despite vetoing the bill, DeSantis proposed several considerations for future legislative work on the issue. He suggested that lawmakers establish guidelines for the handling, cultivation and processing of hemp products to guarantee their purity, safety and potency. According to the governor, the current bill falls short in this regard. DeSantis also suggested selling hemp-derived cannabinoids behind the counter and placing hemp retail stores a safe distance away from places of worship, schools and other gathering places for families with young children.
Essentially, DeSantis is asking voters to reject a ballot proposition that would impose similar rules on the recreational marijuana business, even as he advocates for harsher laws on the hemp-based cannabinoid sector. In the meanwhile, he permits the hemp sector to function without these proposed regulations.
The governor’s veto message was issued a day after a Fox News survey revealed that two-thirds of Florida voters, including a majority of GOP supporters, support the marijuana legalization initiative. According to the survey, 66% of voters support the initiative, surpassing the 60% threshold needed to pass the amendment under state law. In contrast, 52% of voters indicated they either highly or somewhat approve of DeSantis’ performance as governor, highlighting a 14-point disparity in support compared to cannabis legalization.
This calls into doubt the electoral viability of DeSantis’s opposition to the cannabis bill. The governor has maintained that the state should not go beyond the current medical marijuana program, arguing that more extensive reform would have a detrimental effect on Floridians’ standard of living.
The contradictions evident in the governor’s opposition to adult-use cannabis legalization while at the same time shooting down legislation to rein in hemp intoxicants is something that marijuana companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) could find baffling, making the case for federal reforms that are free from the suspected local interests that may have influenced this veto letter.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
by Grow Up Conference | Jun 17, 2024 | Garden Culture Magazine, Media Partners
Building a wicking bed is perfect for your next eco-gardening venture and a great option for the regenerative gardener!
Why wicking beds are a must for the eco-gardener
Ready to level up your regenerative gardening game? Enter the wicking bed! As Stephanie Rose, author of The Regenerative Garden, puts it, a wicking bed is like having a massive self-watering container right in your garden. No wonder these beds are a hit among eco-gardeners looking for sustainable ways to grow plants.
What Is a Wicking Bed?
A wicking bed doesn’t look any different from any in-ground garden or raised bed. What makes it unique is what’s happening below the surface. This type of garden features a reservoir that captures and holds water runoff throughout the growing season, so you don’t have to worry about thirsty plants.
Picture this: make the reservoir base with an impermeable barrier. You’ll need drainage pipes to allow water to flow and gravel to store the water and act as a base for the soil. Place some landscape fabric on the gravel, then the soil and plants.
That’s a wicking bed!
Why Should I Build A Wicking Bed?
Did somebody say less watering with a hose? Plants drink water from the reservoir as needed throughout their growth cycles and become stronger and sturdier. There’s less water waste because there’s less evaporation when the garden gets H20 below the surface. In the era of climate change, any step we take toward preserving and protecting our natural resources matters!
How To Fill A Wicking Bed With Water
Rose recommends directing overflow spouts toward your wicking bed so you can fill them with rainwater (or manually with a hose). She says it’s best to fill it once a week in the summer and every two to three weeks in the spring and fall, less if it rains a lot where you live.
How To Build A Wicking Bed
You can find a comprehensive list of materials and directions in The Regenerative Garden and 79 other sustainable garden projects. This has quickly become one of my favorite books, and I encourage you to grab a copy!
Materials
- 12 cedar fence posts
- ⅜ – x 10” galvanized steel spike nails
- Pond liner measured for the size of the garden bed plus 12” extra on all sides
- Staple gun and staples
- Weeping tile
- ¾” gravel (“clear” gravel only!)
- Dishwasher drain tube (fill tube)
- Landscape fabric
- Remove all weeds from the garden site and level the ground.
- Cut the cedar posts to length and notch the ends by cutting half the depth of each post as deep as the width of the connecting post. Place the two notched side posts directly on the ground, notch side up.
- Set two end posts across the ends of the beds, with the notches facing down on the notches of the side posts. Ensure the four base posts sit flush on the ground to form a square or rectangle.
- Nail spikes into the corners of the posts to keep them in place. Add more layers until you reach the desired bed height, nailing the posts in place as you go.
- Install the pond liner at the bottom of the bed by placing it on the ground and letting it reach about 10” up the sides. Secure temporarily with staples until the gravel holds it down.
- Place coils of weeping tile in the bottom. The tile will help the water move through the reservoir.
- Connect a fill tube to the weeping tile. The fill tube makes things much easier once the soil goes into the bed.
- Add the gravel. The spaces between will fill with water, which will move upwards by capillary action.
- Cover the gravel with landscape fabric to keep the soil out of the reservoir. Now add at least 12” of soil and get planting!
by Grow Up Conference | Jun 17, 2024 | Cannabis News Wire, Media Partners
- Lexaria, a global innovator in drug delivery platforms, recently announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study
- The study, a randomized, crossover investigation, will evaluate a dual-action glucagon-like peptide 1 (“GLP-1”) + glucose-dependent insulintropic peptide (“GIP”)
- It will measure absorption, tolerability, pharmacokinetics, and blood sugar levels
- Lexaria is counting on its patented DehydraTECH technology for significant growth in the 2024 calendar year, and the study reflects this commitment
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study. This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. The manufacturing of test articles for the study is expected to be completed soon, and the approval of an Independent Review Board (“IRB”) will be required before the study commences (https://cnw.fm/A9Vkf).
This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (“GIP”), specifically measuring absorption, tolerability, pharmacokinetics, and blood sugar levels. It will compare injected tirzepatide (Zepbound(R) by Eli Lilly) to a compound formulated, tirzepatide derived from Zepbound(R) and processed by Lexaria’s patented DehydraTECH technology. The objective would be to evaluate whether DehydraTECH-processed tirzepatide, when taken orally, offers any absorption into the human bloodstream and, if so, how much.
This will mark Lexaria’s first-ever work with the tirzepatide molecule while also presenting an opportunity for alternative drug delivery, particularly given that tirzepatide is currently only available in injected form.
“Many GLP-1 drugs have produced unpleasant side effects, especially when dosed through oral tablets,” noted Chris Bunka, Lexaria’s CEO. “Lexaria’s latest study in an oral capsule hopes to evidence improved tolerability while also producing measurable quantities of drug in blood. This will be Lexaria’s first-ever work with the tirzepatide molecule and, as such, any noteworthy delivery of tirzepatide through oral delivery could be a significant finding,” he added.
Lexaria is counting on its DehydraTECH technology for significant growth in the 2024 calendar year. This study reflects this commitment and affirms the leadership’s confidence in the technology. It further looks to build on the technology’s success, as demonstrated in various studies since 2016, having shown its ability to increase bio-absorption compared to standard industry formulations. Lexaria’s management is optimistic that 2024 will be the company’s best year yet, and its tirzepatide study will be a testament to that.
For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
by Grow Up Conference | Jun 17, 2024 | Cannabis Prospect Magazine, Media Partners
Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation. This achievement is a testament of the paradigm shift which will allow patients and the medical industry to consider cannabinoids as the first option, not a last resource.
Its significant valuation is the outcome of our unwavering dedication to growth and our persistent commitment to enhancing standards within the healthcare landscape. With a steadfast focus on maintaining market integrity and propelling scientific evolution, our CEO, Dante Picazo, shares his enthusiasm: “Together, we’re paving the way for the future of healthcare, and we’re enthusiastic about embarking on this shared adventure of advancement.”
At CBIH, we embrace a global approach that integrates neuroscience principals, which are revolutionizing modern medicine with clinical, social, and personal implications by understanding the neural-physical relationship, says Dr. Salguero PhD in Science specialized in Microbiology from São Paulo Brazil University.
To conclude, its tireless dedication to excellence compels them to fortify our message daily with groundbreaking and premium solutions for those who depend on us for their well-being. Cannabis Bioscience International Holdings stands optimally positioned to advance its market footprint, innovate fresh therapeutic alternatives, and reassert its unwavering commitment to innovation and excellence in the cannabis industry. Moving ahead, we maintain relentless resolve in our pursuit to redefine norms and positively influence the future landscape of cannabis-based wellness.
by Grow Up Conference | Jun 17, 2024 | Cannabis News Wire, Media Partners
A new survey has determined that about 25% of cannabis consumers use the drug to manage pain, with most revealing that they preferred fruity strains. The poll analyzed the responses of more than 6,500 consumers of cannabis who were asked questions on their preferences as well as their desired effects, consumption times and flavor profiles.
When asked about their primary goal of consuming cannabis, 25% revealed they used the drug to manage pain, with another 18%, 23%, 7% and 12% revealing that they used the substance to manage stress, anxiety, insomnia and depression respectively. Additionally, 13% of the respondents revealed that they used the substance recreationally.
With regard to time of consumption, 48% of the respondents stated that they used marijuana anytime while 11% admitted to using it at bedtime. Another 29% of them also stated that they used it in the evening, while 4% preferred to indulge in the morning. Another 5% of the respondents preferred to consume the drug in the afternoon.
In addition, the poll asked respondents about the effects they sought in different varieties, with about 30% revealing they wanted to feel relaxed. Another 24% wanted to feel euphoric while 13% wanted to feel uplifted. Another 15% looked for something that made them feel more energetic, 8% wanted to feel sleepy and 10% wanted to be more creative.
Furthermore, the poll asked respondents to list the different marijuana aromas and flavors they preferred, with 27% revealing they liked fruity flavors. Vanilla and citrus flavors were preferred by 6% and 18% of the respondents, respectively, while sweet aromas were wanted by 19%.
In an interview, NuggMD’s head of legal and policy research, Deb Tharp, stated that the findings showed that millions in America were using marijuana for wellness and health reasons, even without medical marijuana recommendations. The survey’s findings align with results of a separate study which determined that while more than 76% of patients used marijuana to manage health symptoms, very few were medical marijuana users.
Tharp explained that marijuana retail was new in some places, adding that more consumer education needed to be done in this space.
The survey was conducted in May, commissioned by NuggMD. The company has carried out a number of surveys centered on marijuana consumer and policy issues. For instance, it announced another poll in April, which determined that most of the voters in America who regularly consumed cannabis believed that Democrats had better ideas for marijuana policy.
The poll also determined that most voters would support political candidates who advocated for marijuana legalization, regardless of their political affiliations.
This poll provides helpful insights into the consumption habits of marijuana consumers, and enterprises such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) can use the data to double down on some strategic actions they have been taking or planning to implement.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
by Grow Up Conference | Jun 17, 2024 | Extraction Magazine, Media Partners
The world is constantly changing, and when it comes to food, sometimes the government needs to work hard to keep up. In the European Union, this is exemplified by the Novel Foods regulations that oversee the marketing and safety of foods that are not traditionally part of European cuisines. Since the first novel food laws were passed in 1997, more than 125 foods received this distinction. [1] After 2017, when the statutes were upgraded, more than 80 additional foods have applied to be included on the novel foods list.
As these laws change, they become increasingly more complicated. Combining this fact with increased interest, it is worth exploring the process of how novel foods are classified within the European Union. The most straightforward way to do this is to focus on botanical products, which not only represent a significant portion of novel foods but a growing source for food stocks in general.
What are Novel Foods?
The term “Novel Foods” was first legally defined in 1997 when the European Commission passed Regulation No. 258/97, entitled “Concerning Novel Foods and Food Ingredients.”[2] The Commission felt that foods considered to be “novel,” or foods not commonly consumed in European markets prior to May 15, 1997, fell into two distinct categories.
- new foods developed using innovative techniques or technologies;
- foods not traditionally consumed in European markets.
Aside from this initial start date, novel foods in Europe are also defined by a few basic criteria. [3] For starters, the foods in question must be safe for human consumption, and they must also be properly labeled. In certain cases, novel foods are marketed as a replacement for an existing food source already available in Europe.
If this is the case, the novel food must demonstrate improved nutritional value beyond the food that it is replacing, creating a nutritional net positive in the overall market. Finally, any novel foods that plan to be sold in the EU must receive authorization from the European Commission prior to their release for mass consumption. This authorization is based on how accurate the data is for the preceding factors, and consists of three basic steps:
- food producers must prove the food is novel;
- food producers must establish a history of consumption;
- food producers have to prove their foods are safe for human consumption.
This application process and evaluation method for novel foods was the standard European practice for 20 years, but it changed on December 31 2017, when the EU released an amended version of these statutes in the form of Regulation no. 1852/2001. [4] These updated policies helped to open the application process further by accounting for new techniques, additional food categories, and exceptions for new food products. While the application process remains the same, the European Commission saw a need to clarify and expand their policies as new applications continued to increase.
This is especially true for botanical products, as they can come in increasingly varied forms and rely on new production methods, making them novel foods by European standards.
Determining if the Food is Novel
The responsibility of identifying whether a new food is in fact novel falls to the food producers themselves. This is not so easily done for several reasons. First, in order for said food to receive the novel distinction, the manufacturer must check each ingredient to determine that it was not being consumed in significant amounts within Europe prior to May 15, 1997. In some instances, this may require providing data on consumption patterns either within the EU or from external regions to establish the food’s ubiquity.
The reason this evaluation process is so complicated has to do with the fact that the EU is made up of 27 countries, many of which have unique regional culinary traditions that could only be common to certain pockets of Europe. As a result, it may be the case that certain foods are consumed in one small part of Europe, but not more readily available throughout the EU.
Beyond ingredients, another way to evaluate whether a food source is novel relates to its preparation method. It may be the case that the plant materials being utilized are common in Europe, but if they are prepared in a new way it may classify the product as novel. This can be an arduous process, requiring the filtering through data from each country. This is a necessary step owing to the fact that the European Union does not maintain an exhaustive database of novel food ingredients or production methods.
Instead, the EU central government only keeps a basic list mostly encompassing broad categories.[5] With this in mind, food producers must sift through different sources of data to prove their food source is novel within Europe. It may sound counterintuitive to prove a negative, but to be considered a novel food, food producers must establish a history of dietary consumption or that their preparation techniques do not exist.
This often requires the work of food experts who can help food manufacturers work through sources from each country, like Italy’s Ministry of Agriculture list of “Traditional agri-food products” or the European Food Safety authority Compendium of Botanicals. [6][7] These lists are updated annually and include traditional recipes and processes that often go back to ancient times. Without the experts’ help, this process is nearly impossible, due to the amount of possible data sources and the potential to overlook something.
Establishing a Safe Use History
If food producers determine that a history of dietary consumption or preparation method do not exist in Europe, they may move on to the next stage of the application process. This portion focuses on the safety of their products for human consumption. The safety of novel botanical products depends on several variables, and each product must be evaluated on a case by case basis. One of the easiest ways to prove a product’s safety is to supply data of human consumption, even if that data is sourced from outside the EU. This is recognized by the EU by establishing a traditional use of the plant.[8]
The European Union considers food to be traditional if it has been used for at least one generation, which typically constitutes a period of 25 years. Considering the fact that plant materials can serve a pharmacological purpose as well as a culinary one, food producers may need to expand the scope of their data on traditional use. If the botanical material produces a physiological response, it may also be necessary to provide evidence that the physiological response of the novel food products do not produce adverse reactions.
Botanical materials that may serve as medicinal supplements are only recognized as traditional if they have been used for a minimum period of 30 years, with at least 15 years of those years being in the EU. Of course, the longer the plant material has been utilized, the more likely the EU will accept the safe use data.
This means that the approval process is simple for products if there are multiple generations having safely consumed the botanical material. Beyond intended use, food producers must also explain the safety of their preparation methods.[9] This also includes several aspects, including factors related to the plant like species, region of origin, harvest period, parts of the plant used, and drying method. This is only the beginning, as the EU also evaluates how the botanical material is extracted, including what kind of is used.
Currently, in the EU, the only solvents that are approved for human consumption are , , ethyl acetate, , carbon dioxide, acetone, and nitrous oxide.[10] Going past these basic details, in order to prove their preparation method is safe, food producer must also prove that the finished product is at least comparable to the original plant material.
Basically, if the botanical food extracts go through any changes, they must not negatively affect the nutrition of the final product. This may mean accounting for chemical changes that could occur during the production phases, including the amount of solvent used, the changes in temperature, or the duration of the extraction process. When evaluating a finished product, it is also worthwhile to compare the concentration of the desired plant’s compound in the extract to the original botanical material.
Meaning that a novel food may choose to increase the concentration of the extract, but the EU wants proof that the higher concentrations won’t hurt consumers. This is relative, though, and food manufacturers can avoid this problem by more shrewdly choosing which plant material they choose to compare their products to. It may be the case that they decide to use a cheaper, but lower concentration botanical material, for the extraction but compare it to a different variation of the same plant to illustrate the differing concentrations have negligible risks.
Depending on data and what materials are sourced for comparison methods, the European commission will either rule that the differences from the manufacturing process are negligible, and thus safe for consumption, or that this may constitute a novel food based on a new production technique. Of course, if it is a novel food based on technique, the food producers may need to provide data that their production method still produces a safe product as well. These small details may constitute the difference between approval and rejection for food producers’ novel foods.
Nanomaterials
One final aspect of novel food regulations that the European Union updated in 2017 is their regulation of nanomaterial engineering. [11] This is an acknowledgement that food technology is advancing, and that regulations need to balance these improvements with the need to protect consumers. Nanomaterial engineering is the manipulation of the food particles within the botanical materials to produce specific results.
This could be in the form of increased nutritional value, lowered fat content, or improved tastes. The regulation of nanomaterials is an ongoing discussion.[12] Recognizing the potential benefits, the European Commission doesn’t want to pass defining legislation, and prefers to evaluate the foods containing nanomaterials on individual bases. Doing so helps to indicate to food producers that they are welcome to experiment, but they must be cautious of any risks that may affect individual consumers or present environmental hazards.
References:
- Ververis, Ermolaos, et al. “Novel foods in the European Union: Scientific requirements and challenges of the risk assessment process by the European Food Safety Authority.” Food Research International 137 (2020): 109515.
- European Commission. (1997, January 27). REGULATION (EC) No 258/97 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 1991 concerning novel foods and novel food ingredients. Retrieved April 23, 2024, from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:31997R0258
- Vapnek, Jessica, Kai Purnhagen, and Ben Hillel. “Regulatory and legislative framework for novel foods.” Food formulation: Novel ingredients and processing techniques (2021): 285-308.
- REGULATION (EU) 2015/2283 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001. (2017, November 25). European Commission. Retrieved April 24, 2024, from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32015R2283&qid=1713947078073
- Establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods. (2017, December 20). Official Journal of the European Union. Retrieved April 24, 2024, from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R2470
- Ministero della Salute. 2022. Circolare ministeriale “Indicazioni sull’uso delle piante e delle loro parti negli integratori alimentari per garantire la sicurezza e tutela dei cittadini”. 27 Maggio 2022.
- European Food Safety Authority. “Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements.” EFSA Journal 10.5 (2012): 2663.
- Hermann, Michael. “The impact of the European Novel Food Regulation on trade and food innovation based on traditional plant foods from developing countries.” Food policy 34.6 (2009): 499-507.
- Bleve, Gianluca, et al. “Identification of safety and quality parameters for preparation of jellyfish based novel food products.” Foods 8.7 (2019): 263.
- Gulati, Om P., and Peter Berry Ottaway. “Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.” Toxicology 221.1 (2006): 75-87.
- Gulati, Om P., and Peter Berry Ottaway. “Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.” Toxicology 221.1 (2006): 75-87.
- European Commission. (2022, June 10). Commission Recommendations on the Definition of Nanomaterials. Official Journal of the European Union. Retrieved April 24, 2024, from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32022H0614(01)
by Grow Up Conference | Jun 16, 2024 | Media Partners, Stratcann
A cannabis store in BC is taking a second swing at hosting a cannabis-friendly patio space, this time in Mission.
Cheeky’s Cannabis, which has two locations in BC, one in Maple Ridge and one in Kitsilano, first briefly launched a similar cannabis-friendly patio in Maple Ridge earlier this year. Then in May, Cheeky’s partnered with the Missions Springs Brewing Company to host an outdoor cannabis-friendly patio to join the large, family-friendly restaurant and brew pub just off Highway 7 in western Mission.
Both businesses are owned, at least in part, by parent company Springs Group, which also helped to bring the two businesses together to create the cannabis consumption space as part of the restaurant.
Customers of the Missions Springs Brewing Company can sit inside or enjoy several outdoor patio spaces. One is smoking-friendly and now also allows cannabis smoking and vaping. Overlooking the Fraser River, customers can order food and drinks and enjoy them while sharing a joint with friends.
Earlier this year, BC began allowing businesses like cafes, restaurants, bars, and casinos that have approved smoking areas to allow cannabis smoking in those same areas. However, municipal bylaws can still be a barrier. A handful of spaces have opened, although many municipalities in the province do not allow these types of smoking areas, regardless of what is being smoked.
Laura Rowse, the co-owner of Cheeky’s Cannabis, says a previous partnership with a restaurant and pub in Maple Ridge called Billy Miner faced too many challenges from city inspectors, prompting her to launch this new space in Mission. The reception at the new space has been positive.
“Billy Miner was a trial, but we really struggled to keep the location in Maple Ridge open”, says Rowse. “Once we gave up on Maple Ridge, then we looked to Mission and the Mission bylaws allow for smoking on patios. We wanted to take a soft approach and not disrupt anybody. The feedback has been good so far.”
The space has about ten tables accessible from the restaurant, with notices on the door that it is a smoking patio. Customers can also choose a nearby non-smoking patio. Rowse says Cheeky’s supplies matches and ashtrays with the store’s branding, and signs within the space that note it’s in partnership with the cannabis store.
by Grow Up Conference | Jun 15, 2024 | Media Partners, Stratcann
This past week, we looked at a recent study that found inaccurate labelling on some cannabis oils in Ontario, and another comparing greenhouse gas emissions from indoor cannabis production in Canada and the US.
Also, Manitobans might be waiting a while before they can legally grow cannabis at home; Indiva received creditor protection; and High Tide shared its Q2 2024 report. We looked at a recent court case involving a First Nation in Nova Scotia, and StatCann’s Tim Wilson dove into some of the roadblocks to selling cannabis in pharmacies.
In other cannabis news this week…
Castanet covered StratCann’s Growing Relationships event in Kelowna, speaking with our very own David Brown.
CBC’s Ontario today spoke with Lynda Balneave at the University of Manitoba and Dr. Hance Clarke – Pain specialist and president of the Canadian Consortium for the Investigation of Cannabinoids about the challenges of self-medicating with cannabis.
Entourage Health Corp. announced the results of its 2024 annual general meeting of shareholders.
High Tide Inc. announced that it has entered into binding subscription agreements with arm’s length institutional credit providers for aggregate gross proceeds of $15 million in a subordinated debt financing.
CTV news reported on a “rise” in illegal cannabis stores in Nova Scotia, although it only referenced four being shut down this year. The province now has 50 legal stores following a recent opening in Shelburne.
The Edmonton Journal had a story on cannabis-induced psychosis involving a young man in Alberta.
Health Canada got a shout-out in High Times.
Vancouver cannabis retailer Kingsway Cannabis is currently listed as closed, with both a sign on their door and a notice on their website referring to a “temporary store closure.” Eggs Canna on Commercial Drive is also now listed as no longer open for business.
A Washington State cannabis company is suing a Vancouver, BC business and two people from Richmond for $2 million for not supplying grow operation equipment as per a 2022 agreement.
International cannabis news
A canna-crisis in Massachusetts was averted this week after a change in regulations meant stores in Martha’s Vineyard and Nantucket will have enough cannabis for the summer rush. Previously, state law did not allow cannabis products to be shipped to the islands off the coast of the Massachusetts mainland for fear of lack of federal jurisdiction.
SFGate has an interesting piece on the challenges facing the California cannabis industry.
And finally, customs officials in Nigeria said they seized 1,072 kilogrammes of cannabis in a shipment from Canada via container ship.
by Grow Up Conference | Jun 14, 2024 | Cannabis News Wire, Media Partners
Cannabis regulators in Ohio have released guidelines to help medical marijuana dispensaries prepare for the application process to obtain dual licenses. These licenses would allow them to serve both medical patients and recreational consumers. Applications are expected to open soon, and the Cannabis Control Department (DCC) has provided a FAQ and detailed instructions to assist potential applicants in starting the process.
The provided materials cover various aspects, such as eligibility requirements, the approval procedure, regulations for dual license holders and the necessary documentation for applications.
One question addresses the timeline for reviewing and issuing dual licenses following the submission of an application. The DCC notes that predicting the exact number of days is challenging because it depends on several factors. These include the completeness of the application, the completion of employee badging, adherence to surveillance standards and the fulfillment of inspection requirements, including standards for POS.
However, a faster turnaround time is anticipated for current medical cannabis license holders that have previously satisfied the dual-use license standards and have properly established their POS.
Applications will typically be reviewed in the order they are submitted and received, but the FAQ highlights that applications from testing laboratories, cultivators and processors will be given precedence to ensure an effective supply chain.
Dual licensees must also ensure they maintain sufficient stock of marijuana to meet the needs of medical patients and avoid shortages. The DCC advises each dispensary to determine the appropriate amount of supply for their operation.
Although Governor Mike DeWine does not support cannabis legalization, he has criticized the delay in access to regulated products since voters approved legalization, which made possession legal last December. There have been legislative discussions about creating a bill to expedite sales and make various changes to the law, but these plans have stalled due to disagreements within the Republican-controlled legislature.
While the Senate passed an amendment package before legalization took effect, the House has not acted on it, nor has it moved forward with a different proposal originating in the House. Senators have also recently introduced a separate bill to modify various marijuana regulations.
Regulators have been completing the recreational market’s regulations in the meantime. They changed the regulations in February, letting caregivers and patients who use medical marijuana obtain or renew their registrations for only a penny. As part of an initial package of rules announced by the DCC in February to effectuate recreational legalization, this fee was fully deleted with the adoption of a new rule at the Joint Committee on Agency Rule Review (JCARR) conference last month.
When the market is finally launched, many entrepreneurs will have a chance to start thriving marijuana businesses similar to entities currently operating in other jurisdictions, such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF).
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
by Grow Up Conference | Jun 14, 2024 | Media Partners, Stratcann
Police in Ontario executed nine search warrants on June 5 in an attempt to shut down six unlicensed “Indige Smoke” cannabis stores.
Ontario Provincial Police (OPP) say they sought to shut down Indige Smoke locations in Hamilton, Fort Erie, Thorold, Welland, St. Catharines, and Leamington.
The enforcement was conducted by the OPP-led Provincial Joint Forces Cannabis Enforcement Team (PJFCET), OPP Organized Crime Enforcement Bureau, and OPP Provincial Asset Forfeiture Unit, with assistance from the Niagara Regional Police Service (NRPS) uniform members and NRPS Emergency Task Unit members.
Police estimate around $1 million worth of cannabis and tobacco was seized, along with weapons and other equipment. Eleven people were arrested and charged with 34 offences. They were released from custody and will appear before the Ontario Court of Justice in St. Catharines on July 18, 2024.
The storefronts are now under Interim Closure Orders under Ontario’s Cannabis Control Act (CCA), which means that no one, including the property owners, can enter those premises unless they first apply to the Superior Court of Justice to get permission under section 18(4) of the CCA. Anyone who enters the buildings without prior permission may be arrested and charged with Break and Enter.
This is at least the second time police have targeted the Indige Smoke stores. In March, three were shut down, seizing products and arresting three people. Those stores were quickly open again following the raids, according to posts on their Instagram account, although at least one location had a notice of Closing Orders posted as well.
While some Indigenous and First Nations activists have argued that they can operate cannabis businesses without provincial or federal oversight, the provincial and federal governments have disagreed. In a recent court case in Nova Scotia, a judge rejected an attempt by several Indigenous cannabis store owners in the province to argue they can operate without provincial approval.
Recent Comments